Menu
 

Search abstracts


Possible pediatric nephrotoxicity of cisplatin

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: ABDELRAHMAN, Sarah (Children's Cancer Hospital Egypt, Department of Pharmaceutical Services & Sciences)
  • Co-author(s): Sarah Mohamed Abdelrahman
    Sarah Salah
    Mahmoud Hamza
    Hala Zaki: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
    Alaa Al Haddad: Department of Pediatric Oncology & Stem Cell Transplant, Children's Cancer Hospital , Cairo, Egypt
    Helmy Moawad: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt
  • Abstract:

    Background

    Risk of Cisplatin (CDDP) nephrotoxicity, increases with increased cumulative dose, bolus dosage and associated nephrotoxic drugs. Early detection & management improves patient care.

    Methods

    51 patients scheduled to receive CDDP-based chemotherapy were recruited and scored for nephrotoxic events throughout chemotherapy course, then

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses